Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials
Autor
Sahebkar A.
Simental-Mendía L.E.
Pirro M.
Montecucco F.
Carbone F.
Banach M.
Barreto G.E.
Butler A.E.
Resumen
Aims: To assess the effect of fibrates on circulating cystatin C levels. Material and methods: Clinical studies evaluating the effect of a fibrate on circulating cystatin C levels were searched in PubMed-Medline, SCOPUS, Web of Science, and Google Scholar databases. A random-effect model and generic inverse variance method were used for quantitative data synthesis, sensitivity analysis conducted using the leave-one-out method, and weighted random-effects meta-regression performed to evaluate potential confounders on cystatin C levels. Results: This meta-analysis of data from nine published studies (16 treatment arms) involved a total of 2195 subjects. In a single-arm analysis of clinical trials (without control group; eight studies comprising 14 treatment arms), fibrate therapy increased circulating cystatin C concentrations (WMD: 0.07 mg/dL, 95% CI: 0.04, 0.10, p <.001; I 2 = 82.66%). When the analysis was restricted to randomized controlled trials (four studies comprising six treatment arms), again elevation of circulating cystatin C levels was observed (WMD: 0.06 mg/L, 95% CI: 0.03, 0.09, p <.001; I 2 = 42.98%). Elevated cystatin C levels were only seen with fenofibrate and not with other fibrates. Conclusions: The results suggest that fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events.Key message Fenofibrate treatment adversely affects cystatin C levels and might partially explain the limited efficacy of fenofibrate in reducing cardiovascular events. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Review
Modulation of heat shock proteins by statins (2020)
Forouzanfar F.; Butler A.E.; Banach M.; Barreto G.E.; Sahbekar A. (Academic Press, 2018) -
Review
PCSK9 and inflammation: A review of experimental and clinical evidence (2020)
Momtazi-Borojeni A.A.; Sabouri-Rad S.; Gotto A.M.; Pirro M.; Banach M.; Awan Z.; Barreto G.E.; Sahebkar A. (Oxford University Press, 2019) -
Article
Ideal Cardiovascular Health and Arterial Stiffness in Spanish Adults—The EVIDENT Study (2020)
García-Hermoso A.; Martínez-Vizcaíno V.; Gomez-Marcos M.; Cavero-Redondo I.; Recio-Rodriguez J.I.; García-Ortiz L. (W.B. Saunders, 2018)